Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism DYRK inhibitors(DYRK kinase inhibitors), PIM family inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neoplasms | Discovery | - | 20 Jun 2024 | |
| Neoplasms | Discovery | - | 20 Jun 2024 | |
| Neoplasms | Discovery | - | 20 Jun 2024 | |
| Nervous System Diseases | Discovery | - | 20 Jun 2024 | |
| Nervous System Diseases | Discovery | - | 20 Jun 2024 | |
| Nervous System Diseases | Discovery | - | 20 Jun 2024 | |
| Other Diseases | Discovery | - | 20 Jun 2024 | |
| Other Diseases | Discovery | - | 20 Jun 2024 | |
| Other Diseases | Discovery | - | 20 Jun 2024 |





